Clinical Development

Our clinical team has extensive experience with clinical affairs in China and globally, take advantage of strong understanding of polices, to develop our differentiated clinical strategy and the schemes. The clinical development department is also accountable for the management of the medical- related and operation related issues through the clinical development process, including enrollment management, follow up and drop out, safety issue handling, quality compliments and audit.

In cooperation with numerous hospitals and principal investigators located in China, Australia and South America that can support our clinical trials of different indications at different stages, our clinical team tight controls of multiple factors including suitability of onsite facilities, availability of qualified staff and availability of research subjects, to exploit the potential of geographic diversity of these facilities which are able to provide us with a significant advantage in implementing large-scale clinical trials and to conduct multiple clinical trials concurrently.

Furthermore, we have engaged external experts as primary investigators of our clinical trials. Conducting clinical researches with safety steering, protocol reviewing, external and internal governance to safeguard patient safety.

Clinical Development

  • image

    Our Phase I Clinical Trial in China

    (ChiCTR2000038152)

    Read More
  • image

    Our Phase II Clinical Trial in China

    (ChiCTR2000040146)

    Read More
  • image

    Phase I/II clinical trial in the U.S.

    (NCT04336410)

    Read More
  • image

    Multicenter Global Phase 3 Clinical Trials

    Read More
icon-top icon-top-hover